Project cooperationUpdated on 5 January 2026
Novel "Innate" Approaches for Vaccines in Low- and Middle-Income Countries
Associate Professor (Italian National Research Council) at Consiglio Nazionale delle Ricerche
Palermo, Italy
About
This project will try to offer a different point-of-view from the pathogen-specific vaccination to a broad-spectrum innate immune preparedness. Novel "vaccine" formulations designed to potently and safely modulate the innate immune system can establish a "quick protectio" of against new viruses. This "trained" or "broadly reactive" immunity could act as a universal first line of defense, controlling early viral replication and reducing severe disease from novel pathogens, independent of a specific vaccine.
The core strategy is to enhance innate immune pathways that are common to many viral families. This approach seeks to provide immediate, cross-protective benefits, buying crucial time for the development and global distribution of specific vaccines.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Organisation
Similar opportunities
Project cooperation
Modified Vaccinia Ankara (MVA) platform for strong T-cell immune responses
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Angelo Raggioli
Head of Technology Development at ReiThera srl
Rome, Italy
Project cooperation
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Daniela Ogonczyk-Makowska
R&D Project Leader at Vaxinano
Loos, France
Project cooperation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Angelo Raggioli
Head of Technology Development at ReiThera srl
Rome, Italy